Interoperability of time series cytometric data: A cross platform approach for modeling tumor heterogeneity

Cytometry Part A

Volumn 79 A, Issue 3, 2011, Pages 214-226

  Khan, Imtiaz A ^a   Lupi, Monica ^b   Campbell, Lee ^a   Chappell, Sally C ^a   Brown, M Rowan ^a   Wiltshire, Marie ^a   Smith, Paul J ^a   Ubezio, Paolo ^b   Errington, Rachel J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Bioinformatics; Cell cycle; Data interoperability; Flow cytometry; Lineage; Mathematical modeling; Timelapse microscopy

Indexed keywords

ARTICLE; BIOLOGICAL MODEL; BIOLOGY; CELL CYCLE; CELL PROLIFERATION; COMPUTER SIMULATION; FLOW CYTOMETRY; HUMAN; METHODOLOGY; MICROSCOPY; NEOPLASM; OSTEOSARCOMA; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; FLOW CYTOMETRY; HUMANS; MICROSCOPY; MODELS, BIOLOGICAL; NEOPLASMS; OSTEOSARCOMA;

EID: 79951962588     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.21023     Document Type: Article

References (51)

1. Valet G. Cytomics, the human cytome project and systems biology: Top-down resolution of the molecular biocomplexity of organisms by single cell analysis. Cell Prolif 2005; 38: 171-174.
2. Megason SG, Fraser SE. Digitizing life at the level of the cell: High-performance laser-scanning microscopy and image analysis for in toto imaging of development. Mech Dev 2003; 120: 1407-1420.
3. Megason SG, Fraser SE. Imaging in systems biology. Cell 2007; 130: 784-795.
4. Wolkenhauer O, Auffray C, Baltrusch S, Bluthgen N, Byrne H, Cascante M, Ciliberto A, Dale T, Drasdo D, Fell D, Ferrell JE Jr, Gallahan D, Gatenby R, Günther U, Harms BD, Herzel H, Junghanss C, Kunz M, van Leeuwen I, Lenormand P, Levi F, Linnebacher M, Lowengrub J, Maini PK, Malik A, Rateitschak K, Sansom O, Schäfer R, Schürrle K, Sers C, Schnell S, Shibata D, Tyson J, Vera J, White M, Zhivotovsky B, Jaster R. Systems biologists seek fuller integration of systems biology approaches in new cancer research programs. Cancer Res 2010; 70: 12-13.
5. Wolkenhauer O, Fell D, De Meyts P, Bluthgen N, Herzel H, Le Novere N, Hofer T, Schurrle K, van Leeuwen I. SysBioMed report: Advancing systems biology for medical applications. IET Syst Biol 2009; 3: 131-136.
6. Smith PJ, Khan IA, Errington RJ. Cytomics and cellular informatics-Coping with asymmetry and heterogeneity in biological systems. Drug Discov Today 2009; 14: 271-277.
7. Jaqaman K, Danuser G. Linking data to models: Data regression. Nat Rev Mol Cell Biol 2006; 7: 813-819.
8. Hastings S, Tyson J, Webster D. Existence of periodic solutions for negative feedback cellular control systems. J Differ Equations 1977; 25: 39-64.
9. Tyson J. On the existence of oscillatory solutions in negative feedback cellular control processes. J Math Biol 1974/75; 1: 311-315.
10. Aguda BD. A quantitative analysis of the kinetics of the G(2) DNA damage checkpoint system. Proc Natl Acad Sci USA 1999; 96: 11352-11357.
11. Aguda BD, Tang Y. The kinetic origins of the restriction point in the mammalian cell cycle. Cell Prolif 1999; 32: 321-335.
12. Tyson J. Cell cycle controls. In: Fall C, Marland E, Wagner J, Tyson J, editors. Computational Cell Biology. New York: Springer; 2002. pp 261-284.
13. Csikász-Nagy A, Battogtokh D, Chen K, Novák B, Tyson JJ. Analysis of a generic model of eukaryotic cell-cycle regulation. Biophys J 2006; 90: 4361-4379.
14. Saez-Rodriguez J, Goldsipe A, Muhlich J, Alexopoulos LG, Millard B, Lauffenburger DA, Sorger PK. Flexible informatics for linking experimental data to mathematical models via DataRail. Bioinformatics 2008; 24: 840-847.
15. Anderson AR, Quaranta V. Integrative mathematical oncology. Nat Rev Cancer 2008; 8: 227-234.
16. Bertuzzi S, Hindges R, Mui SH, O'Leary DD, Lemke G. The homeodomain protein vax1 is required for axon guidance and major tract formation in the developing forebrain. Genes Dev 1999; 13: 3092-3105.
17. Jones TR, Kang IH, Wheeler DB, Lindquist RA, Papallo A, Sabatini DM, Golland P, Carpenter AE. CellProfiler analyst: Data exploration and analysis software for complex image-based screens. BMC Bioinformatics 2008; 9: 482.
18. Echeverri CJ, Perrimon N. High-throughput RNAi screening in cultured cells: A user's guide. Nat Rev Genet 2006; 7: 373-384.
19. Eggert US, Mitchison TJ. Small molecule screening by imaging. Curr Opin Chem Biol 2006; 10: 232-237.
20. Pierrez J, Ronot X. Use of diploid and triploid trout erythrocytes as internal standards in flow cytometry. Cytometry 1991; 12: 275-278.
21. Murphy R, Meijering E, Danuser G. Special issue on molecular and cellular bioimaging. IEEE Trans Image Process 2005; 14: 1233-1236.
22. Systems Biology Report. Systems Biology: A vision for Engineering and Medicine. London: Academy of Medical Sciences; 2007.
23. Jameson D, Turner DA, Ankers J, Kennedy S, Ryan S, Swainston N, Griffiths T, Spiller DG, Oliver SG, White MR, Kell DB, Paton NW. Information management for high content live cell imaging. BMC Bioinformatics 2009; 10: 226.
24. Reif DM, White BC, Moore JH. Integrated analysis of genetic, genomic and proteomic data. Expert Rev Proteomics 2004; 1: 67-75.
25. Zhou X, Wong S. High content cellular imaging for drug development. IEEE Signal Process Mag 2006;23: 170-176.
26. Montalenti F, Sena G, Cappella P, Ubezio P. Simulating cancer-cell kinetics after drug treatment: Application to cisplatin on ovarian carcinoma. Phys Rev E 1998; 57: 5877-5887.
27. Sena G, Onado C, Cappella P, Montalenti F, Ubezio P. Measuring the complexity of cell cycle arrest and killing of drugs: Kinetics of phase-specific effects induced by taxol. Cytometry 1999; 37: 113-124.
28. Cunningham RE. Overview of flow cytometry and fluorescent probes for cytometry. Methods Mol Biol 1999; 115: 249-256.
29. Khan IA, Hedley CJ, White NS, Ali R, Chappell MJ, Evans ND, Campbell L, Marquez N, Fisher J, Smith PJ, Errington RJ. A novel integrative bioinformatics environment for encoding and interrogating timelapse microscopy images. In: Feng D, editor. Modelling and Control in Biomedical Systems. Reims: Elsevier; 2006. pp 273-278.
30. Khan IA, Husemann P, Campbell L, White NS, White RJ, Smith PJ, Errington RJ. ProgeniDB: A novel cell lineage database for generation associated phenotypic behavior in cell-based assays. Cell Cycle 2007; 6: 868-874.
31. Ubezio P. Microcomputer experience in analysis of flow cytometric DNA distributions. Comput Programs Biomed 1985; 19: 159-166.
32. Arino O. A survey of structured cell population dynamics. Acta Biotheor 1995; 43: 3-25.
33. Spinelli L, Torricelli A, Ubezio P, Basse B. Modelling the balance between quiescence and cell death in normal and tumour cell populations. Math Biosci 2006; 202: 349-370.
34. Ubezio P, Lupi M, Branduardi D, Cappella P, Cavallini E, Colombo V, Matera G, Natoli C, Tomasoni D, D'Incalci M. Quantitative assessment of the complex dynamics of G1, S, and G2-M checkpoint activities. Cancer Res 2009; 69: 5234-5240.
35. Lupi M, Cappella P, Matera G, Natoli C, Ubezio P. Interpreting cell cycle effects of drugs: The case of melphalan. Cancer Chemother Pharmacol 2006; 57: 443-457.
36. Lupi M, Matera G, Natoli C, Colombo V, Ubezio P. The contribution of p53 in the dynamics of cell cycle response to DNA damage interpreted by a mathematical model. Cell Cycle 2007; 6: 943-950.
37. Aitkin M, Anderson D, Francis B, Hinde J. Statistical Modelling in GLIM. Oxford: Clarendon Press; 1989.
38. Steel G. Cell Population Kinetics in Relation to the Growth and Treatment of Cancer. Growth Kinetics of Tumors. Oxford: Clarendon Press; 1977.
39. Sisken JE, Morasca L. Intrapopulation kinetics of the mitotic cycle. J Cell Biol 1965; 25: 179-189.
40. Errington RJ, Marquez N, Chappell SC, Wiltshire M, Smith PJ. Time-lapse microscopy approaches to track cell cycle progression at the single-cell level. Curr Protoc Cytom 2005; Chapter 12:Unit 12.4.
41. Jain KK. Challenges of drug discovery for personalized medicine. Curr Opin Mol Ther 2006; 8: 487-492.
42. Valet G. Cytomics: An entry to biomedical cell systems biology. Cytometry A 2005; 63A: 67-68.
43. Kohn KW. Molecular interaction map of the mammalian cell cycle control and DNA repair systems. Mol Biol Cell 1999; 10: 2703-2734.
44. Valet GK, Tarnok A. Cytomics in predictive medicine. Cytometry B Clin Cytom 2003; 53B: 1-3.
45. Tyson JJ, Novak B. Regulation of the eukaryotic cell cycle: Molecular antagonism, hysteresis, and irreversible transitions. J Theor Biol 2001; 210: 249-263.
46. Kar S, Baumann WT, Paul MR, Tyson JJ. Exploring the roles of noise in the eukaryotic cell cycle. Proc Natl Acad Sci USA 2009; 106: 6471-6476.
47. Clyde R, Bown J, Hupp T, Zhelev N, Crawford J. The role of modelling in identifying drug targets for diseases of the cell cycle. J R Soc Interface 2006; 10: 617-627.
48. Sible JC, Tyson JJ. Mathematical modeling as a tool for investigating cell cycle control networks. Methods 2007; 41: 238-247.
49. Gray JW, Bogart E, Gavel DT, George YS, Moore DH II. Rapid cell cycle analysis. II. Phase durations and dispersions from computer analysis of RC curves. Cell Tissue Kinet 1983; 16: 457-471.
50. Endy D, Brent R. Modelling cellular behaviour. Nature 2001; 409: 391-395.
51. Brown MR, Summers HD, Rees P, Smith PJ, Chappell SC, Errington RJ. Flow-based cytometric analysis of cell cycle via simulated cell populations. PLoS Comput Biol 2010; 6: e1000741.